FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Infinimmune
Fierce Biotech, a division of Forge, names Infinimmune a “Fierce 15” Biotech Company of 2026
October 05, 2026
From
Infinimmune
Via
Business Wire
Infinimmune Raises $75 Million Series A Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease
August 11, 2026
From
Infinimmune
Via
Business Wire
Infinimmune Appoints Srikanth Pendyala, M.D., as Chief Medical Officer
May 13, 2026
From
Infinimmune
Via
Business Wire
Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy
April 27, 2026
From
Infinimmune
Via
Business Wire
Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics
March 31, 2026
From
Infinimmune
Via
Business Wire
Infinimmune Announces Research Collaboration with Immunome
September 18, 2025
From
Infinimmune
Via
Business Wire
Tickers
IMNM
Infinimmune Launches GLIMPSE-1 AI Model Trained Exclusively on Human Antibody Sequences for Advanced Therapeutic Engineering
June 12, 2025
From
Infinimmune
Via
Business Wire
Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer
September 03, 2024
From
Infinimmune
Via
Business Wire
Infinimmune Appoints Dr. Neela Patel to Board of Directors
May 15, 2024
From
Infinimmune
Via
Business Wire
Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery
December 19, 2023
From
Infinimmune
Via
Business Wire
Infinimmune Raises $12 Million in Seed Funding to Pioneer Novel Approach to Antibody Drug Discovery and Development
December 06, 2022
From
Infinimmune
Via
Business Wire
